From: Salvage thoracic surgery in patients with lung cancer: potential indications and benefits
Total (n = 30) | Group 1 (n = 22) | Group 2 (n = 3) | Group 3 (n = 5) | |
---|---|---|---|---|
Age (years, ± SD) | 63 ± 7 | 63 ± 8 | 64 ± 3 | 62 ± 8 |
Male/Female | 26/4 | 21/1 | 3/0 | 2/3 |
Presence of comorbidity (n, %) | 18 (60%) | 11 (50%) | 2 (67%) | 5 (100%) |
Operation type (n) | ||||
Lobectomy | 14 | 11 | 0 | 3 |
Greater resection | 11a | 8b | 2c | 1d |
Segmentectomy | 5 | 3 | 1 | 1 |
Extended resection (n, %)** | 16 (53%) | 13 (59%) | 1 (33%) | 2 (40%) |
Length of hospital stay (mean days ± SD) | 11 ± 4 | 10 ± 4 | 14 ± 2 | 13 ± 9 |
Mortality (n, %) | 1 (3%) | 0 | 0 | 1 (20%) |
Morbidity (n, %) | 21 (70%) | 14 (64%) | 3 (100%) | 4 (80%) |
Overall survival (mean months ± SD) | 19 ± 13 | 22 ± 13 | 13 ± 5 | 6 ± 2 |
Relapse-free survival (mean months ± SD) | 14 ± 12 | 16 ± 13 | 9 ± 4 | 6 ± 2 |